المؤلفون: Tiffany C; GSK, Collegeville, Pennsylvania, USA., Dumont EF; GSK, Collegeville, Pennsylvania, USA., Hossain M; GSK, Collegeville, Pennsylvania, USA., Srinivasan M; GSK, Collegeville, Pennsylvania, USA., Swift B; GSK, Research Triangle Park, North Carolina, USA.

المصدر: Clinical and translational science [Clin Transl Sci] 2022 Sep; Vol. 15 (9), pp. 2251-2264. Date of Electronic Publication: 2022 Jul 13.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

مواضيع طبية MeSH: Single-Blind Method*, Acenaphthenes ; Administration, Oral ; Adult ; Aged ; Cross-Over Studies ; Dose-Response Relationship, Drug ; Double-Blind Method ; Healthy Volunteers ; Heterocyclic Compounds, 3-Ring ; Humans

المؤلفون: Monaghan TF; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Agudelo CW; Division of Cardiovascular Medicine, Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA., Rahman SN; Department of Urology, Yale University School of Medicine, New Haven, CT 06520, USA., Wein AJ; Division of Urology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA., Lazar JM; Division of Cardiovascular Medicine, Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA., Everaert K; Department of Human Structure and Repair, Ghent University, 9000 Ghent, Belgium., Dmochowski RR; Department of Urological Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

المصدر: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2021 Jun 24; Vol. 57 (7). Date of Electronic Publication: 2021 Jun 24.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE

مواضيع طبية MeSH: Single-Blind Method*, Bias ; Double-Blind Method ; Humans

المؤلفون: Murthy V; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States. Electronic address: venkatesha.murthy2@takeda.com., Hanson E; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States., DeMartinis N; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States., Asgharnejad M; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States., Dong C; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States., Evans R; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States., Ge T; Neurocrine Biosciences, Inc., San Diego, California, United States., Dunayevich E; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States; Neurocrine Biosciences, Inc., San Diego, California, United States., Singh JB; Neurocrine Biosciences, Inc., San Diego, California, United States., Ratti E; Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, United States., Galderisi S; University of Campania Luigi Vanvitelli, Naples, Italy.

المصدر: Schizophrenia research [Schizophr Res] 2024 Aug; Vol. 270, pp. 249-257. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2509 (Electronic) Linking ISSN: 09209964 NLM ISO Abbreviation: Schizophr Res Subsets: MEDLINE

مواضيع طبية MeSH: Schizophrenia*/drug therapy , D-Amino-Acid Oxidase*/antagonists & inhibitors, Humans ; Male ; Female ; Adult ; Double-Blind Method ; Middle Aged ; Single-Blind Method ; Young Adult ; Antipsychotic Agents/pharmacology ; Antipsychotic Agents/administration & dosage ; Antipsychotic Agents/adverse effects ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/administration & dosage ; Enzyme Inhibitors/adverse effects ; Outcome Assessment, Health Care

المؤلفون: Czumbel N; Department of Ophthalmology, Jahn Ferenc Del-pesti Korhaz es Rendelointezet, Köves u. 1, Budapest, 1204, Hungary. czumbel@gmail.com., Acs T; Ophthalmology Department, Hospital of BacsKiskun County, Nyiri út 38, Kecskemet, H-6000, Hungary., Bator G; Markusovszky Egyetemi Oktatokorhaz, Department of Ophthalmology, Markusovszky u. 5, Szombathely, 9700, Hungary., Halmosi A; Markusovszky Egyetemi Oktatokorhaz, Department of Ophthalmology, Markusovszky u. 5, Szombathely, 9700, Hungary., Egorov EA; Ophthalmology Department, Pirogov Russian National Research Medical University, 1 Ostrovityanov str, Moscow, 117997, Russia., Maltsev DS; Kirov Military Medical Academy of Ministry of Defense of the Russian Federation, 6 Acad. Lebedev str, Saint-Petersburg, 194044, Russia.

المصدر: BMC ophthalmology [BMC Ophthalmol] 2024 Jul 29; Vol. 24 (1), pp. 313. Date of Electronic Publication: 2024 Jul 29.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Multicenter Study; Randomized Controlled Trial; Comparative Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Latanoprost*/therapeutic use , Glaucoma, Open-Angle*/drug therapy , Glaucoma, Open-Angle*/physiopathology , Intraocular Pressure*/drug effects , Ocular Hypertension*/drug therapy , Antihypertensive Agents*/therapeutic use , Antihypertensive Agents*/adverse effects , Cross-Over Studies* , Ophthalmic Solutions*, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Drugs, Generic/therapeutic use ; Drugs, Generic/adverse effects ; Treatment Outcome ; Preservatives, Pharmaceutical/therapeutic use ; Single-Blind Method ; Tonometry, Ocular ; Double-Blind Method

المؤلفون: Golubic R; Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK., Kennet J; Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Parker V; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Robertson D; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Luo D; Statistics, Biometrics Oncology, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA., Hansen L; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Jermutus L; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Ambery P; Late Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Ryaboshapkina M; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Surakala M; R&D IT, AstraZeneca, Cambridge, UK., Laker RC; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Venables M; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK., Koulman A; MRC Epidemiology Unit, University of Cambridge, Cambridge, UK., Park A; Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK., Evans M; Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2634-2644. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Obesity*/drug therapy , Obesity*/complications , Energy Intake*/drug effects , Weight Loss*/drug effects , Energy Metabolism*/drug effects, Humans ; Male ; Female ; Middle Aged ; Double-Blind Method ; Adult ; Hypoglycemic Agents/therapeutic use ; Hypoglycemic Agents/pharmacology ; Receptors, Glucagon/agonists ; Glucagon-Like Peptide 1/agonists ; Single-Blind Method ; Aged ; Glucagon-Like Peptide-1 Receptor/agonists ; Treatment Outcome ; Peptides

المؤلفون: Dellink A; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: annelies.dellink@uantwerpen.be., Hebbrecht K; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Department of Psychiatry, University Psychiatric Center KU Leuven, Leuven, Belgium., Zeeuws D; Department of Psychiatry, Universitair Ziekenhuis Brussel, Brussels, Belgium; Neuroprotection and Neuromodulation Research Group (NEUR), Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium., Baeken C; Department of Psychiatry, Universitair Ziekenhuis Brussel, Brussels, Belgium; Neuroprotection and Neuromodulation Research Group (NEUR), Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium; Ghent Experimental Psychiatry (GHEP) Lab, Ghent University, Ghent, Belgium., De Fré G; Sint-Maria Halle Hospital, Belgium., Bervoets C; Department of Psychiatry, University Psychiatric Center KU Leuven, Leuven, Belgium., De Witte S; Neuroprotection and Neuromodulation Research Group (NEUR), Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium; Ghent Experimental Psychiatry (GHEP) Lab, Ghent University, Ghent, Belgium., Sabbe B; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Morrens M; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Coppens V; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Duffel, Duffel, Belgium; Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

المصدر: Journal of affective disorders [J Affect Disord] 2024 Sep 15; Vol. 361, pp. 693-701. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2517 (Electronic) Linking ISSN: 01650327 NLM ISO Abbreviation: J Affect Disord Subsets: MEDLINE

مواضيع طبية MeSH: Bipolar Disorder*/therapy , Bipolar Disorder*/blood , Kynurenine*/blood , Transcranial Magnetic Stimulation*/methods , Quinolinic Acid*/blood , Kynurenic Acid*/blood , Tryptophan*/blood, Humans ; Double-Blind Method ; Female ; Male ; Adult ; Middle Aged ; Treatment Outcome ; Psychiatric Status Rating Scales ; Biomarkers/blood

المؤلفون: Zhang H; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Shan AD; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Wan CH; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Cao XY; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Yuan YS; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Ye SY; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Gao MX; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Gao LZ; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Tong Q; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Gan CT; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Sun HM; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China., Zhang KZ; Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, China. Electronic address: kezhong_zhang1969@126.com.

المصدر: Journal of affective disorders [J Affect Disord] 2024 Sep 15; Vol. 361, pp. 556-563. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2517 (Electronic) Linking ISSN: 01650327 NLM ISO Abbreviation: J Affect Disord Subsets: MEDLINE

مواضيع طبية MeSH: Parkinson Disease*/therapy , Parkinson Disease*/physiopathology , Parkinson Disease*/psychology , Parkinson Disease*/complications , Vagus Nerve Stimulation*/methods , Anxiety*/therapy , Anxiety*/physiopathology , Transcutaneous Electric Nerve Stimulation*/methods , Prefrontal Cortex*/physiopathology, Humans ; Male ; Female ; Middle Aged ; Double-Blind Method ; Aged ; Spectroscopy, Near-Infrared ; Treatment Outcome

المؤلفون: Xue L; Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom. Electronic address: lingfeng.xue@kcl.ac.uk., Bocharova M; Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom., Young AH; Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom., Aarsland D; Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.

المصدر: Journal of affective disorders [J Affect Disord] 2024 Sep 15; Vol. 361, pp. 74-81. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2517 (Electronic) Linking ISSN: 01650327 NLM ISO Abbreviation: J Affect Disord Subsets: MEDLINE

مواضيع طبية MeSH: Duloxetine Hydrochloride*/therapeutic use , Vortioxetine*/therapeutic use , Vortioxetine*/pharmacology , Antidepressive Agents*/therapeutic use , Age of Onset* , Cognition*/drug effects, Humans ; Female ; Male ; Aged ; Middle Aged ; Treatment Outcome ; Psychiatric Status Rating Scales ; Depressive Disorder, Major/drug therapy ; Aged, 80 and over ; Depression/drug therapy ; Double-Blind Method

المؤلفون: El-Haggar SM; Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, El-Guiesh Street, El-Gharbia Government, Tanta 31527, Egypt., Hegazy SK; Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, El-Guiesh Street, El-Gharbia Government, Tanta 31527, Egypt., Maher MM; Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; Internal Medicine Department, Faculty of Medicine, Horus University, New Damietta, Egypt., Bahgat MM; Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; Internal Medicine Department, Faculty of Medicine, Horus University, New Damietta, Egypt., Bahaa MM; Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt. Electronic address: mbahaa@horus.edu.eg.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Sep 10; Vol. 138, pp. 112541. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Metformin*/therapeutic use , Colitis, Ulcerative*/drug therapy , Mesalamine*/therapeutic use, Humans ; Double-Blind Method ; Male ; Female ; Adult ; Middle Aged ; STAT3 Transcription Factor/metabolism ; STAT3 Transcription Factor/genetics ; Drug Repositioning ; Haptoglobins/metabolism ; Interleukin-6/blood ; Zonula Occludens-1 Protein/metabolism ; Zonula Occludens-1 Protein/genetics ; Cholera Toxin ; Intercellular Adhesion Molecule-1/blood ; Intercellular Adhesion Molecule-1/genetics ; Intercellular Adhesion Molecule-1/metabolism ; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Tumor Necrosis Factor-alpha/blood ; Colon/pathology ; Colon/drug effects ; Treatment Outcome ; Young Adult ; Drug Therapy, Combination ; Protein Precursors

المؤلفون: Zielen S; Department of Pediatrics, Goethe University, Frankfurt, Germany., Crawford T; Department of Neurology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA., Benatti L; EryDel, Bresso, Italy., Magnani M; Department of Biomolecular Sciences, University of Urbino, Urbino, Italy., Kieslich M; Department of Pediatrics, Goethe University, Frankfurt, Germany., Ryan M; Department of Neurology, Royal Children's Hospital, Parkville, VIC, Australia., Meyts I; Department of Pediatrics, University Hospital Leuven, Leuven, Belgium., Gulati S; Department of Pediatrics, Centre of Excellence and Advanced Research for Childhood Neuro-developmental Disorders and Child Neurology Division, All India Institute of Medical Sciences, New Delhi, India., Borgohain R; Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, India., Yadav R; Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India., Pal P; Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India., Hegde A; Department of Neurology, Jaslok Hospital and Medical Research Center, Mumbai, India., Kumar S; Department of Neurology, Vijaya Hospital, Chennai, India., Venkateswar A; Department of Neurology, Vijaya Hospital, Chennai, India., Udani V; Pediatric Neurology, Hinduja National Hospital and Research Center, Mumbai, India., Vinayan KP; Pediatric Neurology, Amrita Institute of Medical Sciences, Kochi, India., Nissenkorn A; Children's Neurology Clinic, Sheba Medical Centre, Tel-Hashomer, School of Medicine, Tel Aviv University, Tel Aviv, Israel., Fazzi E; Child Neurology and Psychiatry Unit, Civil Hospital, and Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Leuzzi V; Department of Neurosciences and Mental Health, La Sapienza University, Rome, Italy., Stray-Pedersen A; Norwegian National Unit for Newborn Screening, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Pietrucha B; Department of Immunology, The Children's Memorial Health Institute, Warsaw, Poland., Pascual SI; Department of Pediatric Neurology, Hospital Universitario La Paz Madrid, Madrid, Spain., Gouider R; Neurology Department, Clinical Investigation Center 'Neurosciences and Mental Health', Razi Hospital, Tunis, Tunisia., Koenig MK; Department of Pediatrics, Division of Child and Adolescent Neurology, UT Health, McGovern Medical School, Houston, TX, USA., Wu S; Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Perlman S; Department of Neurology, Ataxia Center, and Huntington's Disease Center of Excellence, University of California, Los Angeles, CA, USA., Thye D; Quince Therapeutics, South San Francisco, CA, USA., Janhofer G; EryDel, Bresso, Italy., Horn B; Quince Therapeutics, South San Francisco, CA, USA. Electronic address: bhorn@quincetx.com., Whitehouse W; Paediatric Neurology, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust and School of Medicine University of Nottingham, Nottingham, UK., Lederman H; Division of Pediatric Allergy and Immunology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.

المصدر: The Lancet. Neurology [Lancet Neurol] 2024 Sep; Vol. 23 (9), pp. 871-882.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Dexamethasone*/administration & dosage , Dexamethasone*/analogs & derivatives , Ataxia Telangiectasia*/drug therapy, Humans ; Double-Blind Method ; Child ; Female ; Male ; Adolescent ; Treatment Outcome ; Erythrocytes/drug effects